News Sansure Biotech Inc.

Equities

688289

CNE1000043J1

End-of-day quote Shanghai S.E. Other stock markets 03:30:00 30/04/2024 am IST			5-day change	1st Jan Change
20.46 ^CNY	+1.49%		+11.62%	+4.65%

26/04	Sansure Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
29/02	Sansure Biotech's 2023 Profit Drops 81% as Revenue Slumps 84%	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sansure Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	27/04	CI
Sansure Biotech's 2023 Profit Drops 81% as Revenue Slumps 84%	29/02	MT
Sansure Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/02	CI
ASEP Medical Holdings Signs JV Agreement with Chinese Medical Diagnostics Co Sansure Biotech Inc.	22/11	MT
Sansure Biotech Secures EU Certification For In Vitro Diagnostic Device	15/11	MT
Sansure Biotech Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/23/30	CI
Tranche Update on Sansure Biotech Inc.'s Equity Buyback Plan announced on October 21, 2022.	11/23/11	CI
Sansure Biotech Inc.'s Equity Buyback announced on October 21, 2022, has closed with 9,865,793 shares, representing 1.7% for CNY 200 million.	09/23/09	CI
Sansure Biotech Gets EU CE certification for 60 products	22/23/22	MT
Certain A Shares of Sansure Biotech Inc. are subject to a Lock-Up Agreement Ending on 28-AUG-2023.	28/23/28	CI
Sansure Biotech Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	16/23/16	CI
Sansure Biotech's Human Papillomavirus Kit Gets EU Registration Certificate	27/23/27	MT
Tranche Update on Sansure Biotech Inc.'s Equity Buyback Plan announced on October 21, 2022.	01/23/01	CI
Sansure Biotech Inc.(SHSE:688289) dropped from Shanghai Stock Exchange Health Care Sector Index	09/23/09	CI
Sansure Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	25/23/25	CI
Tranche Update on Sansure Biotech Inc.'s Equity Buyback Plan announced on October 21, 2022.	05/23/05	CI
Sansure Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	27/23/27	CI
Asep Inc. Lower After Signing JV Term Sheet with Leading Chinese Medical Diagnostic Co. Sansure Biotech Inc.	30/23/30	MT
Sansure Biotech Gets Certification for COVID-19 Kit	30/23/30	MT
ASEP Medical Holdings Inc. Signs Joint Venture Term Sheet with Sansure Biotech Inc. in Preparation for the Commercialization of the Sepset(ER) Sepsis Diagnostic Test in China	28/23/28	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Sansure Biotech Inc.

Equities

688289

CNE1000043J1

Summary

Filters